EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Cardiovascular effectiveness of newer glucose-lowering agents, with and without baseline lipid-lowering therapy in type 2 diabetes: A systematic meta-analysis of cardiovascular outcome trials and real-world evidence

Setor K Kunutsor, Borenyi S Seidu, Samuel Seidu

Primary Care Diabetes · 2024-12 · 18 (6) · 589-598

DOI: 10.1016/j.pcd.2024.09.007 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Primary Care Diabetes, 2024-12. Verfasst von Setor K Kunutsor und 2 weiteren Autor:innen. Beteiligte Einrichtung: Leicester Real World Evidence Unit, Diabetes Research Centre, University of Leicester, Leicester General Hospital, Gwendolen Road, Leicester LE5 4WP,…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Cardiovascular Diseases, Sodium-Glucose Transporter 2 Inhibitors, Glucagon-Like Peptide-1 Receptor Agonists. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Cardiovascular DiseasesSodium-Glucose Transporter 2 InhibitorsGlucagon-Like Peptide-1 Receptor AgonistsHumansTreatment OutcomeHydroxymethylglutaryl-CoA Reductase InhibitorsRisk AssessmentHypoglycemic AgentsFemaleMaleBlood GlucoseClinical Trials as TopicMiddle AgedAgedHypolipidemic Agents

Stichwörter der Autor:innen

Cardiovascular diseaseGLP-1RARandomised controlled trialSGLT-2iStatinsType 2 diabetes

Substanzen

Sodium-Glucose Transporter 2 InhibitorsHydroxymethylglutaryl-CoA Reductase InhibitorsHypoglycemic AgentsBlood GlucoseHypolipidemic AgentsGlucagon-Like Peptide-1 Receptor Agonists

Autor:innen und Institutionen

  • Leicester Real World Evidence Unit, Diabetes Research Centre, University of Leicester, Leicester General Hospital, Gwendolen Road, Leicester LE5 4WP, UK.
  • Leicester Real World Evidence Unit, Diabetes Research Centre, University of Leicester, Leicester General Hospital, Gwendolen Road, Leicester LE5 4WP, UK; The University of Manchester, Manchester, UK.
  • Leicester Real World Evidence Unit, Diabetes Research Centre, University of Leicester, Leicester General Hospital, Gwendolen Road, Leicester LE5 4WP, UK. Electronic address: sis11@leicester.ac.uk.

Zitieren

APA

Kunutsor, S. K., Seidu, B. S., & Seidu, S. (2024). Cardiovascular effectiveness of newer glucose-lowering agents, with and without baseline lipid-lowering therapy in type 2 diabetes: A systematic meta-analysis of cardiovascular outcome trials and real-world evidence. Primary Care Diabetes, 18(6), 589-598. https://doi.org/10.1016/j.pcd.2024.09.007

Vancouver

Kunutsor SK, Seidu BS, Seidu S. Cardiovascular effectiveness of newer glucose-lowering agents, with and without baseline lipid-lowering therapy in type 2 diabetes: A systematic meta-analysis of cardiovascular outcome trials and real-world evidence. Primary Care Diabetes. 2024;18(6):589-598. doi:10.1016/j.pcd.2024.09.007

BibTeX
@article{Kunutsor2024,
  author = {Kunutsor, Setor K and Seidu, Borenyi S and Seidu, Samuel},
  title = {Cardiovascular effectiveness of newer glucose-lowering agents, with and without baseline lipid-lowering therapy in type 2 diabetes: A systematic meta-analysis of cardiovascular outcome trials and real-world evidence},
  journal = {Primary Care Diabetes},
  year = {2024},
  volume = {18},
  number = {6},
  pages = {589--598},
  doi = {10.1016/j.pcd.2024.09.007}
}
Kostenlos starten →